Status:

COMPLETED

Feasibility of a Hepatitis C Virus (HCV) Decision-Making Intervention Among HIV-infected Adults

Lead Sponsor:

University of Massachusetts, Worcester

Collaborating Sponsors:

National Institute of Nursing Research (NINR)

Conditions:

Hepatitis c

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of the LEAP-C (learning, experiencing and preparing for hepatitis C treatment) study is to see if a brief (4-week) small group intervention will help people with HIV/HCV co-infection make ...

Detailed Description

Chronic Hepatitis C Virus (HCV) infection is a major problem for Human Immunodeficiency Virus (HIV)-infected patients. Without HCV treatment, increasing numbers of HIV positive patients will die eithe...

Eligibility Criteria

Inclusion

  • Men and Women (18 years of age or older) who have both HIV and chronic Hepatitis C (they need to have a detectable Hepatitis C viral load)
  • HIV/HCV co-infected adults who have NEVER started treatment
  • HIV/HCV co-infected adults who DO NOT have a MEDICAL reason that would make it dangerous to treat their hepatitis C (for example, severe cirrhosis already)
  • HIV/HCV co-infected adults who would be willing to be RANDOMIZED into a group session or standard of care (one on one care with a HCV provider)

Exclusion

  • Non-English Speaking
  • Children under age 18
  • HCV mono-infected adults
  • HIV/HCV co-infected adults who have received any HCV treatment

Key Trial Info

Start Date :

October 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 1 2012

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT01472354

Start Date

October 1 2010

End Date

November 1 2012

Last Update

May 30 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Massachusetts Graduate School of Nursing

Worcester, Massachusetts, United States, 01655